These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [The role of cyclooxygenase-2 and vascular endothelial growth factor-C in lymphatic metastasis of gastric cancer].
    Author: Liu J, Yu JP, Wang XL, Zhou XD, Yu HG.
    Journal: Zhonghua Nei Ke Za Zhi; 2004 Nov; 43(11):841-4. PubMed ID: 15634545.
    Abstract:
    OBJECTIVE: It has been known that cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF)-C are closely related with the development of tumors. To investigate the expression of COX-2 and VEGF-C in gastric cancer and the correlation between them. METHODS: Sixty-four paraffin-embedded gastric cancer samples and 22 flesh gastric cancer samples were tested with using immunohistochemistry method and the reverse transcription-polymerase chain reaction technology respectively. RESULTS: The mean expressive density of COX-2 and VEGF-C mRNA in gastric cancer were both significantly higher than those in non-cancerous gastric mucosa (1.363 +/- 0.351 vs 0.763 +/- 0.304, 0.972 +/- 0.331 vs 0.314 +/- 0.215, P < 0.001). The positive rates of COX-2 and VEGF-C in 64 gastric cancer samples were 72% and 64% respectively. Their expression in the groups of lymph-node metastasis were higher than that of the non-lymph-node metastasis groups respectively (P < 0.05). Moreover, there was a close correlation between COX-2 and VEGF-C expression levels (P < 0.05). CONCLUSIONS: There are high COX-2 and VEGF-C expression in gastric cancer. Gastric tumor tissues that produce VEGF-C may have a higher lymphatic invasion and metastatic potential. COX-2 may participate in VEGF-C lymphangiogenic pathway and the high expression of them may play an important role in the lymphatic proliferation and spread in gastric cancer.
    [Abstract] [Full Text] [Related] [New Search]